CHiR Therapy for Elderly DLBCL Intolerant to Chemo

NCT06764017 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

NETWORK

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: CHiR-DEL

Sponsor

First Affiliated Hospital of Ningbo University